Infertility treatment is increasingly gaining popularity among male and female population across the globe who are unable to conceive or reproduce naturally. A continual shift toward sedentary lifestyle, rise in physical inactivity, excessive consumption of alcohol, smoking, stress, delayed pregnancy, improper fetal care, rise in prevalence of obesity and diabetes and others may increase the issues associated with natural reproduction and infertility. This increases the preference of patients to opt for infertility treatment options.
According to a market report published by Bizwit Research & Consulting, LLP, global infertility treatment market is valued approximately USD 2.08 billion in 2020 and is anticipated to grow with a healthy growth rate of nearly 8.35% over the forecast period 2021-2027.
Declining fertility rate among the population, the rise in number of fertility clinics, increasing public-private investments, funds, and grants, and increasing medical tourism due to low treatment costs are some of the factors that are expected to significantly contribute towards the growth of global infertility treatment market during the forecast period. In addition, investments in research and development and advancements in infertility treatment devices provides lucrative growth opportunities to the market. However, complication associated with treatment and high cost of procedure are expected to hamper the market growth.
Declining fertility rate among the population is one of the major factors which is expected to contribute towards the growth of global infertility treatment market during the forecast period. Declining fertility rate can be majorly attributed to changing lifestyles of population, shift toward sedentary lifestyle, rise in physical inactivity, and others. There has been a decline witnessed in the fertility rate in different countries across the globe. For instance, according to the World Bank, the fertility rate, total (births per woman) in the United States was 1.844 in 2015 which decreased to 1.705 in 2019. Also, the fertility rate, total (births per woman) in Japan was 1.45 in 2015 which decreased to 1.36 in 2019. Such decline in the rate of fertility is expected to increase the consumer demand for infertility treatment methods and procedures and hence promote the growth of global infertility treatment market during the forecast period.
Global Infertility Treatment Market Size study, by Product (Equipment, Media & Consumables, and Accessories), by Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries, and Other Infertility Treatment Procedures), by Patient Type (Female Infertility Treatment, and Male Infertility Treatment), by End User (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, and Research Institutes), and Regional Forecasts 2021-2027
The total market revenue is calculated on the basis of revenue generated through the sale of procedures and surgeries performed such as assisted reproductive technology, artificial insemination, fertility surgeries and other infertility treatment procedure, etc. Major companies covered under the report are The Cooper Companies Inc., Cook Group, Vitrolife, Thermo Fisher Scientific, Inc., Esco Lifesciences Group, Genea Biomedx, IVFtech ApS, FUJIFILM Irvine Scientific, Rocket Medical plc, and Kitazato Corporation.
Review the reports at https://www.bizwitresearch.com/
Data drives better decisions
Bizwit Research & Consulting LLP